| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 6 |
| 1 | SPIRONOLACTONE | 6 |
| 2 | ERGOCALCIFEROL | 5 |
| 3 | FINASTERIDE | 5 |
| 4 | OMEPRAZOLE | 5 |
| 5 | OMEPRAZOLE MAGNESIUM | 5 |
| 6 | SIMVASTATIN | 5 |
| 7 | USTEKINUMAB | 5 |
| 8 | ASPIRIN | 4 |
| 9 | ASPIRIN 325 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFTAZIDIME, AVIBACTAM | 1 | 0.0059 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 2 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 3 | CARIPRAZINE | 2 | 0.0002 |
| 4 | TOLVAPTAN | 3 | 0.0002 |
| 5 | RALTEGRAVIR | 1 | 0.0002 |
| 6 | ETONOGESTREL AND ETHINYL ESTRADIOL | 4 | 0.0002 |
| 7 | ERGOCALCIFEROL | 5 | 0.0002 |
| 8 | UBROGEPANT | 1 | 0.0002 |
| 9 | SELEXIPAG | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Aluminum Complex [EPC] | 2 | 0.0001 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 7 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 8 | Interleukin-23 Antagonist [EPC] | 6 | 0.0001 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 5 | 0.0000 |